Long-Term Efficacy of Migalastat on Renal Function and Outcomes in Patients with Fabry Disease (FD)

被引：0
|
作者：
Bichet, Daniel G. [1 ]
Feldt-Rasmussen, Ulla [2 ]
Giugliani, Roberto [3 ,4 ]
Hughes, Derralynn [5 ,6 ]
Krusinska, Eva [7 ]
Veleva-Rotse, Biliana O. [7 ]
机构：
[1] Univ Montreal, Hop Sacre Coeur, Dept Med, Montreal, PQ, Canada
[2] Natl Univ Hosp, Rigshosp, Dept Med Endocrinol & Metab, Copenhagen, Denmark
[3] Univ Fed Rio Grande do Sul, Dept Genet, HCPA, Med Genet Serv, Porto Alegre, RS, Brazil
[4] INAGEMP, Porto Alegre, RS, Brazil
[5] Royal Free London NHS Fdn Trust, Lysosomal Storage Disorders Unit, London, England
[6] UCL, London, England
[7] Amicus Therapeut Inc, Philadelphia, PA USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO1312
引用
收藏
页码：420 / 421
页数：2
相关论文
共 50 条
  • [21] PRELIMINARY LONG-TERM SAFETY, TOLERABILITY, AND ASSESSMENTS OF RENAL FUNCTION OF ADULT FABRY PATIENTS RECEIVING TREATMENT WITH AT1001 (MIGALASTAT HYDROCHLORIDE), A PHARMACOLOGICAL CHAPERONE, FOR UP TO 3 YEARS
    Hughes, D.
    Adera, M.
    Castelli, J.
    Bragat, A.
    Marsden, D. L.
    Boudes, P. B.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S148 - S148
  • [22] Long-term safety and efficacy of enzyme replacement therapy for Fabry disease
    Wilcox, WR
    Banikazemi, M
    Guffon, N
    Waldek, S
    Lee, P
    Linthorst, GE
    Desnick, RJ
    Germain, DP
    AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 75 (01) : 65 - 74
  • [23] Long-term efficacy and safety of agalsidase alfa in women with Fabry disease
    Whybra, C.
    Kampmann, C.
    Miebach, E.
    Gal, A.
    Baron, K.
    Beck, M.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : 107 - 107
  • [24] Long-term efficacy and safety of enzyme replacement therapy in Fabry disease
    Germain, DP
    Caplan, L
    Eng, CM
    Guffon, N
    Lee, P
    Linthorst, G
    Waldeck, S
    Wilcox, WR
    Desnick, RJ
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 70 - 70
  • [25] Bilateral renal cell carcinoma development in long-term Fabry disease
    Cassiman, D.
    Claes, K.
    Lerut, E.
    Oyen, R.
    Joniau, S.
    Van Damme, B.
    Jaeken, J.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 (05) : 830 - 831
  • [26] Renal function and Fontan patients: What is the real impact in the long-term outcomes?
    Binotto, Maria Angelica
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 306 : 86 - 87
  • [27] Reply: Impact of Cardio-Renal Syndrome on adverse outcomes in patients with Fabry disease in a long-term follow-up
    Nowak, Albina
    Siegenthaler, Martin
    Namdar, Mehdi
    Ruschitzka, Frank
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 258 : 206 - 206
  • [28] CLINICAL OUTCOMES WITH MIGALASTAT IN PATIENTS WITH FABRY DISEASE BASED ON DEGREE OF RENAL IMPAIRMENT: RESULTS FROM PHASE 3 TRIALS
    Torra, Roser
    Germain, Dominique
    Bichet, Daniel
    Schiffmann, Raphael
    Yu, Julie
    Castelli, Jeffrey
    Skuban, Nina
    Barth, Jay
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [29] Combined heart and kidney transplantation in Fabry's disease: Long-term outcomes in two patients
    Ba, S. -N. Tran
    Lidove, O.
    Dorent, R.
    Debauchez, M.
    Nataf, P.
    Delahousse, M.
    Karras, A.
    Azeroual, L.
    De Lentdecker, P.
    Chauveheid, M. P.
    Sene, T.
    Ziza, J. -M.
    REVUE DE MEDECINE INTERNE, 2017, 38 (02): : 137 - 142
  • [30] Long-term outcomes in patients with obesity and renal disease after sleeve gastrectomy
    Kassam, Al-Faraaz
    Mirza, Ahmad
    Kim, Young
    Hanseman, Dennis
    Woodle, E. Steve
    Quillin, Ralph C., III
    Johnson, Bobby L.
    Govil, Amit
    Cardi, Michael
    Schauer, Daniel P.
    Smith, Eric P.
    Diwan, Tayyab S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (02) : 422 - 429
12345